Independent · evidence-based · non-judgmentalDraft · pending medical review
Not yet medically reviewed — information on this site is in preparation and has not been verified by a medical reviewer.
Drug index / Prescription / Scopolamine (Devil's Breath)
Prescription

Scopolamine (Devil's Breath)

[(1S,2S,4R,5R)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate

Scopolamine (hyoscine, 'Devil's Breath') is a prescription anticholinergic and tropane alkaloid used medically for motion sickness and post-operative nausea, most familiar as the behind-the-ear Transderm Scop patch. It is not a DEA-scheduled controlled substance, but it is dangerous: at higher doses it causes disorientation, memory loss, and suggestibility, and it is best known for its use in drug-facilitated crimes via spiked drinks.

Overview

Scopolamine, also called hyoscine or 'Devil's Breath', is an anticholinergic medication and belladonna (tropane) alkaloid derived from nightshade-family plants such as henbane, jimsonweed, and datura. Medically it is FDA-approved for motion sickness and post-operative nausea and to reduce secretions before surgery, most commonly delivered as a low-dose transdermal patch worn behind the ear. It has a centuries-long history in medicine and a darker modern reputation tied to its use in crime, especially in parts of South America.

Source: FDA (DailyMed label); Wikipedia (CC-BY-SA); peer-reviewed literature (NIH/PMC)

Chemistry & mechanism of action

Scopolamine is a muscarinic acetylcholine receptor antagonist: it blocks the action of acetylcholine, a key neurotransmitter, in the brain and body. This anticholinergic action reduces nausea and secretions (its medical uses) but at higher exposures disrupts memory formation, attention, and awareness, producing confusion, amnesia, and a suggestible, disoriented state. It readily crosses the blood-brain barrier, which is why central effects are prominent.

Source: peer-reviewed literature (NIH/PMC); FDA

Effects

At the low, controlled doses of a medical patch, effects are mainly side effects: dry mouth, blurred vision, drowsiness, and dizziness. At higher or non-medical doses scopolamine produces disorientation, confusion, hallucinations, and a striking loss of memory for the period of intoxication, along with a passive, suggestible mental state. It is not typically described as euphoric or pleasant, which is part of why it has low recreational appeal.

Source: FDA (DailyMed label); peer-reviewed literature (NIH/PMC)

Risks & harms

Scopolamine's dangers fall into two categories. Medically and in overdose, it is a potent anticholinergic: too much causes a toxidrome of fast heart rate, dilated pupils, high temperature, urinary retention, confusion, toxic psychosis, vivid hallucinations, seizures, and at severe levels coma. The FDA label specifically warns against combining it with alcohol or other CNS depressants, which deepens confusion, disorientation, and sedation. The second, higher-profile danger is criminal: because scopolamine powder is colorless and tasteless, it has been used to spike victims' food or drinks in robberies, kidnappings, and sexual assaults, exploiting the drug's ability to render someone compliant and amnesic. Reports of incapacitation by 'blowing powder in the face' are pharmacologically dubious and likely exaggerated, but drink-spiking is a documented, real risk. There is no recreational safe-use pattern here; effects are unpleasant and the margin to serious toxicity is narrow. Anyone showing severe agitation, high fever, a racing heart, seizures, or unresponsiveness needs emergency care — call 911, and Poison Control at 1-800-222-1222 can advise. This page has not yet been medically reviewed.

Source: FDA (DailyMed label); peer-reviewed literature (NIH/PMC); SAMHSA

Images

Visual references coming soon.

If it’s too intense

If an experience becomes overwhelming, the goal is to stay safe and let it pass — most difficult experiences ease as the drug wears off.

  • Get to a calm, safe space with someone you trust who is sober and can stay with you.
  • Cool down if you’re overheating — move somewhere cool, remove extra layers, rest. Overheating is especially a risk with stimulants and MDMA.
  • Sip water to thirst — but don’t over-hydrate. Drinking large amounts of plain water (especially after MDMA) can dangerously dilute your blood sodium (hyponatremia). Electrolytes help more than volume.
  • Slow your breathing — long, slow exhales help settle a racing heart and anxiety.
  • A sugary drink, fruit juice, or a snack can ease shakiness and the anxiety that comes with low blood sugar.
  • Do not take more, and do not add another substance to manage it. Redosing or adding something else (including a sedative like a benzodiazepine) can make things worse, not better.
Call 911 (or Poison Control, 1-800-222-1222) right away for chest pain, a very high body temperature, a seizure, unconsciousness, or severe confusion. These are medical emergencies, not something to wait out.

Source: general harm-reduction guidance from SAMHSA, NIH/NIDA, and MedlinePlus, in our own words. Draft — not yet medically reviewed.

Forensic dossier

Draft · every field is source-cited or marked “Unknown — pending review”

Identity

IUPAC name
[(1S,2S,4R,5R)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoatePubChem PUG-REST · retrieved 2026-06-18
SMILES
CN1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4PubChem PUG-REST · retrieved 2026-06-18
InChIKey
STECJAGHUSJQJN-USLFZFAMSA-NPubChem PUG-REST · retrieved 2026-06-18
Synonyms / aliases
devil's breath, hyoscine, Scopace, Boro-Scopol, scopolamine, Hyoscine, (-)-Hyoscine, Scopine tropate, Transderm-Scop, (-)-Scopolamine, Scopine (-)-tropate, AtrochinPubChem PUG-REST + seed aliases · retrieved 2026-06-18

Composition

Composition
N/A — single compound (see Identity)

Physical / pill characteristics

Dosage form
Unknown — pending review (no Rx/OTC label; illicit — pill visuals = FIRST-PARTY submissions only, never generated or scraped)
Route
Unknown — pending review
Shape
Unknown — pending review
Color
Unknown — pending review
Imprint
Unknown — pending review
Score
Unknown — pending review

Scheduling & legal status

US schedule
Unknown — pending review
International
See EMCDDA/EUDA + WHO — synthesize per jurisdictionEMCDDA / EUDA · retrieved 2026-06-18

Effects

Effects
Cited source pending synthesis — author in our words from NIDA/MedlinePlus on review (NOT auto-generated)NIDA + MedlinePlus · retrieved 2026-06-18

Risks

Risks
Cited source pending synthesis — author in our words from NIDA/MedlinePlus on review (NOT auto-generated)NIDA + MedlinePlus · retrieved 2026-06-18

Interactions

Interactions
Unknown — pending review

Dosage

Pending medical reviewer

Sources

← Back to the drug index